Profit from pest control with Rentokil Initial
Rentokil Initial is set for global expansion and offers strong sales growth
One of the recurring themes of this column is that some of the best opportunities are provided by firms in industries that aren’t glamorous but are important. One industry that certainly fits the bill is pest control. If you run a restaurant, you’ll know how vital pest control is to your survival, as no one wants to eat in a place with flies in their soup – or worse. Similarly, as emerging markets become richer and people move into cities, their tolerance for pests dwindles. Rentokil Initial (LSE: RTO) is one company perfectly positioned to take advantage.
Founded in the UK just over 100 years ago, Rentokil dominates the UK market and has expanded overseas by acquiring companies in other countries and integrating them into the Rentokil brand. The most notable of these purchases was US company Terminix in 2022, which made Rentokil the largest company in the US, the biggest market in the world. Rentokil is now the world’s biggest pest-control company, operating in 90 countries, including virtually all of the world’s largest cities.
Rentokil Initial has ambitious plans for growth
The global pest-control market is expected to grow by 5%-6% a year over the next few years, and Rentokil has ambitious plans for giving its growth a further fillip. Firstly, it wants to expand into the countries where it doesn’t have a presence. It is also investing in digital technology to make its operations more effective and to keep costs down.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The group also plans to expand its hygiene and washrooms business, which currently accounts for 20% of its revenue. At the same time, the sale of its workwear business to HIG Capital in October 2025 will not only make it a tidy sum of money but will also help keep the company streamlined and focused. Rentokil has seen its revenue double between 2019 and 2024, while its earnings per share have gone up by nearly two-thirds during the same period (and are expected to keep growing rapidly over the next few years). The company makes a solid 7% return on capital employed, a key gauge of profitability, and boasts a double-digit operating margin, which has helped it increase its dividend sixfold from 2019, while still investing in the business and keeping debt at manageable levels. All this more than justifies the fact that it trades at 19.4 times 2026 earnings; the stock also offers a dividend yield of 2.2%. In addition to strong fundamentals,
Rentokil’s stock has plenty of momentum. Over the second half of 2025, Rentokil was one of the stars of the FTSE 100, rising 38%. As a result, the shares trade well above their 50 and 200-day moving averages. With several brokers, including Morgan Stanley, recently upgrading Rentokil, I suggest that you buy it at the current price of 471p at £6 per 1p. In that case, I would put the stop-loss at 316p, which would give you a total downside of £930.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

-
Tap income and capital growth in markets worldwideOpinion Three investment trusts with potential for capital growth, selected by Adam Norris, co-portfolio manager of the CT Global Managed Portfolio Trust
-
Are buyers returning to the fine art market?Wealthy bidders returned to the fine-art market last summer, amid rising demand from younger buyers. What does this mean for 2026?
-
Three funds to buy for capital growth and global incomeOpinion Three investment trusts with potential for capital growth, selected by Adam Norris, co-portfolio manager of the CT Global Managed Portfolio Trust
-
Fine-art market sees buyers returnWealthy bidders returned to the fine-art market last summer, amid rising demand from younger buyers. What does this mean for 2026?
-
PayPoint: a promising stock for income-seekersPayPoint, a household name across Britain, is moving away from its traditional roots toward a digital future. Investors after a steady income should buy in
-
Investing in forestry: a tax-efficient way to grow your wealthRecord sums are pouring into forestry funds. It makes sense to join the rush, says David Prosser
-
The MoneyWeek investment trust portfolio – early 2026 updateThe MoneyWeek investment trust portfolio had a solid year in 2025. Scottish Mortgage and Law Debenture were the star performers, with very different strategies
-
Pundits had a bad 2025 – here's what it means for investorsThe pundits came in for many shocks in 2025, says Max King. Here is what they should learn from them
-
The MoneyWeek ETF portfolio – early 2026 updateThe MoneyWeek ETF portfolio had a solid year in 2025 and looks well placed for what the next 12 months may bring
-
'Investors should brace for Trump’s great inflation'Opinion Donald Trump's actions against Federal Reserve chair Jerome Powell will likely stoke rising prices. Investors should prepare for the worst, says Matthew Lynn